Concorde Specialty Gases, Inc. – Trademark Portfolio
Entity Type: 03
Concorde Specialty Gases, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include CONCORDETRAK. The owner is based in Eatontown, NJ.
36 Eaton Road
Eatontown, NJ 07724
Showing of trademarks Trademarks
Trademark Classifications
Concorde Specialty Gases, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does Concorde Specialty Gases, Inc. have?
Concorde Specialty Gases, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned, 1 cancelled.
What trademark classes does Concorde Specialty Gases, Inc. file in?
Concorde Specialty Gases, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Concorde Specialty Gases, Inc.'s most well-known trademarks?
Concorde Specialty Gases, Inc.'s registered trademark portfolio includes well-known marks such as CONCORDETRAK. These are among 1 currently registered trademark in the portfolio.
What is Concorde Specialty Gases, Inc.'s trademark registration success rate?
Concorde Specialty Gases, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.